Patents by Inventor Martin Borch Jensen

Martin Borch Jensen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240150751
    Abstract: Provided herein are compositions and methods of use thereof for screening a plurality of uniquely identifiable therapeutic moieties by identifying one or more reporters indicative of a cell state. The methods include the administration of a library of expression cassettes, comprising a plurality of nucleic acid sequences, each encoding a different therapeutic moiety operably linked to a therapeutic moiety barcode; a plurality of nucleic acid sequences encoding one or more reporters that collectively, when expressed in a cell or an isolated nucleus, are indicative of a cell state or a likelihood of a cell state of the cell; and one or more sequences encoding a non-coding nuclear retention RNA motif.
    Type: Application
    Filed: April 22, 2022
    Publication date: May 9, 2024
    Inventors: Martin Borch Jensen, Daniel Fuentes
  • Patent number: 11739370
    Abstract: Provided herein are compositions and methods of use thereof for screening a plurality of uniquely identifiable therapeutic moiety in vivo by identifying one or more reporters indicative of a cell state.
    Type: Grant
    Filed: January 7, 2021
    Date of Patent: August 29, 2023
    Assignee: Gordian Biotechnology, Inc.
    Inventor: Martin Borch Jensen
  • Publication number: 20230265416
    Abstract: Provided herein are libraries of delivery vehicles and methods of uses thereof. The delivery vehicles provided include distinct variants of a virus and nucleic acid sequences encoding a distinct virus-identifying barcode region specific for each virus variants, and a nucleic acid sequence encoding at least one reporter. The methods provided herein include methods of identifying a vehicle effective in targeting a particular cell type.
    Type: Application
    Filed: May 10, 2021
    Publication date: August 24, 2023
    Inventors: Martin Borch Jensen, Daniel Fuentes
  • Publication number: 20220017894
    Abstract: Provided herein are compositions and methods of use thereof for screening a plurality of uniquely identifiable therapeutic moiety in vivo by identifying one or more reporters indicative of a cell state.
    Type: Application
    Filed: November 6, 2019
    Publication date: January 20, 2022
    Inventors: Martin Borch Jensen, Francisco LePort